American Journal of Epidemiology Vol. 153, No. 1 : 31-37
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Bone Mass and the Risk of Colon Cancer among Postmenopausal Women
The Framingham Study
1 Boston University Arthritis Center, Boston University School of Medicine, Boston, MA.
2 Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, MA.
3 Section of General Internal Medicine, Evans Department of Medicine, Boston University School of Medicine, Boston, MA.
4 Framingham Heart Study, Framingham, MA.
5 National Heart, Lung, and Blood Institute, Bethesda, MD.
6 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
7 Division of Population Science, Fox Chase Cancer Center, Philadelphia, PA.
8 Department of Epidemiology and Biostatistics, Boston University School of Public Health, Boston, MA.
9 Hebrew Rehabilitation Center for Aged, Boston, MA.
10 Harvard Medical School Division on Aging, Boston, MA.
Although postmenopausal estrogen use has been associated with a lower risk of colon cancer in women, some studies do not confirm such findings. No known study has examined the effect of cumulative estrogen exposure on colon cancer risk. Bone mass has been proposed as a marker of cumulative exposure to endogenous and exogenous estrogens. By using data on 1,394 Massachusetts women in the Framingham Study who underwent hand radiography in 1967–1970, the authors examined the association between bone mass (from relative areas of the second metacarpal) and colon cancer incidence. Over 27 years of follow-up, 44 incident colon cancer cases occurred. Colon cancer incidence decreased from 2.19 per 1,000 person-years among the women in the lowest age-specific tertile of bone mass to 1.59 and 1.08 among women in the middle and the highest tertiles, respectively. After adjustment for age and other potential confounding factors, the rate ratios of colon cancer were 1.0, 0.7 (95% confidence interval: 0.3, 1.3), and 0.4 (95% confidence interval: 0.2, 0.9) from the lowest to the highest tertile (p for trend = 0.033). No association was found between bone mass and rectal cancer. The findings suggest that women with higher bone mass, perhaps reflecting greater cumulative estrogen exposure, have a decreased risk of colon cancer.
bone density; cohort studies; colorectal neoplasms; estrogens
Abbreviations: CI, confidence interval
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. BROZEK, S. KRIWANEK, E. BONNER, M. PETERLIK, and H. S. CROSS Mutual Associations between Malignancy, Age, Gender, and Subsite Incidence of Colorectal Cancer Anticancer Res, September 1, 2009; 29(9): 3721 - 3726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Stevens and E. Schernhammer Epidemiology of Uriniary Melatonin in Women and Its Relation to Other Hormones and Night Work Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 551 - 551. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. S. Tan, S. Seshadri, A. Beiser, Y. Zhang, D. Felson, M. T. Hannan, R. Au, P. A. Wolf, and D. P. Kiel Bone Mineral Density and the Risk of Alzheimer Disease Arch Neurol, January 1, 2005; 62(1): 107 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Pocock, T. J Collier, K. J Dandreo, B. L de Stavola, M. B Goldman, L. A Kalish, L. E Kasten, and V. A McCormack Issues in the reporting of epidemiological studies: a survey of recent practice BMJ, October 16, 2004; 329(7471): 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L.C. Hagemans, Y. T. van der Schouw, M. J.J. de Kleijn, W. A. van Staveren, V. J.M. Pop, G. L. Leusink, and D. E. Grobbee Indicators for the total duration of premenopausal endogenous estrogen exposure in relation to BMD Hum. Reprod., September 1, 2004; 19(9): 2163 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Samelson, D. P. Kiel, K. E. Broe, Y. Zhang, L. A. Cupples, M. T. Hannan, P. W. F. Wilson, D. Levy, S. A. Williams, and V. Vaccarino Metacarpal Cortical Area and Risk of Coronary Heart Disease: The Framingham Study Am. J. Epidemiol., March 15, 2004; 159(6): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Chlebowski, J. Wactawski-Wende, C. Ritenbaugh, F. A. Hubbell, J. Ascensao, R. J. Rodabough, C. A. Rosenberg, V. M. Taylor, R. Harris, C. Chen, et al. Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women N. Engl. J. Med., March 4, 2004; 350(10): 991 - 1004. [Abstract] [Full Text] [PDF]
|
|